Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
Revenue
Mayinglong Pharmaceutical Group Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
Revenue
¥3.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Revenue
¥31.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's Revenue?
Revenue
3.2B
CNY
Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Revenue amounts to 3.2B CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%
Over the last year, the Revenue growth was -12%. The average annual Revenue growth rates for Mayinglong Pharmaceutical Group Co Ltd have been 8% over the past three years , 8% over the past five years , and 7% over the past ten years .